Example: Heart Attack

Search clinical trials for: Antithrombin III

Total 916 results

NCT04454775

Completed

Raloxifene on Coagulation System in the Postmenopausal Women

Conditions: Raloxifene; Postmenopausal Women
NCT04447378

Completed

Safety of Fondaparinux as Post Partum Thromboprophylaxis

Conditions: Thromboembolism in the Puerperium
NCT04444804

Not yet recruiting

Study to Compare the Effectiveness of Rivaroxaban (Xarelto) Versus Low-molecular-weight Heparin (LMWH) and Phenprocoumon for the Treatment and Secondary Prevention of Venous Thromboembolism in Routine Clinical Practice in Germany

Conditions: Venous Thromboembolism
NCT04445935

Recruiting

Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial

Conditions: Anticoagulation in COVID-19 ARDS
NCT04437654

Not yet recruiting

The Efficacy and Safety of Non-vItamiN K antaGonist oraL Anticoagulants for intermEdiate Stroke Risk in Patients With Atrial Fibrillation (SINGLE-AF)

Conditions: Atrial Fibrillation Patients With Intermediate Stroke Risk
NCT04435418

Completed

Eliquis Acute Stroke Safety Evaluation

Conditions: Ischemic Stroke; Transient Ischemic Attack; Atrial Fibrillation
NCT04432220

Not yet recruiting

AnticoaguLation ONE Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation (ALONE AF Study)

Conditions: Atrial Fibrillation Patients With Moderate or High Stroke Risk Who Had Undergone Catheter Ablation of Atrial Fibrillation
NCT04433481

Not yet recruiting

Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein Thrombosis

Conditions: Liver Cirrhosis; Portal Vein Thrombosis
NCT04424381

Completed

Pharmacokinetics and Bioequivalence of Rivaroxaban Tablet in Healthy Chinese Volunteers

Conditions: Healthy Subjects
NCT04416048

Not yet recruiting

Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19

Conditions: COVID-19
NCT04406389

Not yet recruiting

Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial)

Conditions: COVID-19
NCT04401761

Recruiting

A Study to Collect Data on the Treatment Pattern of Xarelto + Acetylsalicylic Acid in the Routine Clinical Practice in Patients Who Are Suffering From a Condition That Narrows the Blood Vessels Supplying the Heart and / or a Condition That Most Commonly Narrows the Blood Vessel in the Legs

Conditions: Coronary Artery Disease (CAD)
NCT04397289

Recruiting

Anticoagulation Therapy After Splenectomy in Cirrhosis Patient

Conditions: Liver Cirrhosis; Portal Hypertension; Anticoagulant-induced Bleeding; Thrombosis
NCT04394377

Recruiting

Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial

Conditions: Coronavirus Infection
NCT04380220

Active, not recruiting

Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis

Conditions: Multiple Sclerosis; Relapse
NCT04368377

Completed

Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19

Conditions: Pneumonia, Viral; Corona Virus Infection; Respiratory Failure; Embolism and Thrombosis
NCT04359212

Not yet recruiting

Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19

Conditions: COVID-19 Disease; Thromboembolism, Venous
NCT04356989

Recruiting

Study to Gain Information on the Drug Xarelto for the Prevention of Brain Attack and Blockage of an Artery in the Non-central Nervous System Due to Irregular Heartbeat in Taiwanese Patients Suffering From Decreased Renal Function

Conditions: Non-valvular Atrial Fibrillation (NVAF)
NCT04351724

Recruiting

Austrian CoronaVirus Adaptive Clinical Trial (COVID-19)

Conditions: COVID-19
NCT04347824

Recruiting

Predict Adverse Events by Covid-19 Nephritis

Conditions: Covid-19
NCT04344717

Not yet recruiting

Pharmacokinetics of Apixaban in Patients With Short Bowel Syndrome Requiring Long Term Parenteral Nutrition

Conditions: Short Bowel Syndrome; Anticoagulation
NCT04333407

Recruiting

Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.

Conditions: COVID-19
NCT04324463

Recruiting

Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial

Conditions: Coronavirus; Severe Acute Respiratory Syndrome
NCT04315974

Recruiting

Italian Registry In the Setting of AF Ablation With Rivaroxaban (IRIS)

Conditions: Atrial Fibrillation
NCT04309240

Not yet recruiting

Rivaroxaban for Thromboprophylaxis in High-risk Cancer Patients With Totally Implantable Access Ports

Conditions: Rivaroxaban; Thromboprophylaxis; Cancer
NCT04305028

Not yet recruiting

Influence of Rivaroxaban for Intermittent Claudication and Exercise Tolerance in Patients With Symptomatic PAD

Conditions: Peripheral Arterial Disease
NCT04298567

Not yet recruiting

Study to Learn More About the Effectiveness and Safety of Rivaroxaban (Xarelto) When Given Together With Acetylsalicylic Acid to Patients Suffering From a Condition That Affects the Blood Vessels Supplying the Heart (CAD) and/or a Condition That Affects the Blood Vessel of the Lower Limbs (PAD).

Conditions: Coronary Artery Disease(CAD); Peripheral Artery Disease(PAD)
NCT04297072

Active, not recruiting

Study to Gather Information on the Kidney Function of Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem) Treated With Rivaroxaban or Vitamin K Antagonists

Conditions: Non-Valvular Atrial Fibrillation
NCT04297150

Recruiting

Predictive Factors for Response to New Oral Anticoagulants in the Treatment of Non-valvular Atrial Fibrillation..

Conditions: Atrial Fibrillation
NCT04284839

Not yet recruiting

The Direct Oral Anticoagulation Versus Warfarin After Cardiac Surgery Trial

Conditions: Bleeding Post Cardiac Surgery; Indication for Anticoagulation
NCT04278729

Not yet recruiting

A Prospective Multi-dose Study of Apixaban in Subjects With Nephrotic Syndrome

Conditions: Nephrotic Syndrome; Membranous Nephropathy
NCT04275180

Recruiting

Clinical Study of Argatroban in the Treatment of Acute Progressive Ischemic Stroke

Conditions: Acute Progressive Ischemic Stroke
NCT04273516

Not yet recruiting

Rivaroxaban Plus ASA in Embolic Stroke of Undetermined Source(AREST-ESUS)

Conditions: Stroke; Prevention
NCT04271293

Recruiting

Oral Anti-coagulants in Fragile Patients With Percutaneous Endoscopic Gastrostomy and Atrial Fibrillation (ORIGAMI) Pilot Study

Conditions: Atrial Fibrillation
NCT04262492

Not yet recruiting

International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants

Conditions: Antiphospholipid Syndrome; Thrombosis; Anticoagulants Causing Adverse Effects in Therapeutic Use
NCT04263038

Recruiting

Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism

Conditions: Pulmonary Embolism; Embolism; Embolism and Thrombosis; Lung Diseases; Cardiovascular Diseases; Respiratory Tract Diseases; Venous Thromboembolism; Anticoagulant-induced Bleeding; Bleeding
NCT04258488

Not yet recruiting

Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacement

Conditions: AORTIC VALVE DISEASES; Thromboembolism
NCT04256525

Recruiting

Prophylactic Anticoagulation for Catheter-related Thrombosis

Conditions: Venous Thrombosis Due to Central Venous Access Device (Disorder); Prophylactic Anticoagulation; Patients With Tumor
NCT04257032

Suspended

A Study in Healthy Men to Test the Influence of BI 1323495 on the Amount of the Medicines Rosuvastatin and Dabigatran in the Blood

Conditions: Healthy
NCT04249401

Active, not recruiting

Study to Gather Information About the Safety of Oral Anticoagulation Drugs and How Well These Drugs Work in Real World for Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem)

Conditions: Atrial Fibrillation
NCT04250116

Not yet recruiting

Appropriate Duration of Anti-Platelet and Thrombotic Strategy After 12 Months in Patients With Atrial Fibrillation Treated With Drug Eluting Stents

Conditions: Atrial Fibrillation
NCT04243122

Not yet recruiting

Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patients

Conditions: Myeloproliferative Neoplasm; Essential Thrombocythemia; JAK2 Mutation; Polycythemia Vera; Primary Myelofibrosis; Venous Thromboembolism
NCT04244981

Not yet recruiting

Efficacy of Prothrombin Complex Concentrate Reducing Perioperative Blood Loss in Cardiac Surgery

Conditions: Cardiac Surgical Procedures
NCT04229264

Recruiting

Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients.

Conditions: Critical Limb Ischemia
NCT04219579

Recruiting

Antithrombin III Concentrate After Liver Transplantation

Conditions: Liver Transplant; Complications
NCT04218266

Recruiting

Study to Gather Information About the Proper Dosing of the Oral FXIa Inhibitor BAY 2433334 and to Compare the Safety of the Study Drug to Apixaban, a Non-vitamin K Oral Anticoagulant (NOAC) in Patients With Irregular Heartbeat (Atrial Fibrillation) That Can Lead to Heart-related Complications.

Conditions: Atrial Fibrillation (AF)
NCT04218656

Not yet recruiting

DUAL Pathway Inhibition to Improve Endothelial Function in Peripheral Artery Disease

Conditions: Peripheral Artery Disease
NCT04218890

Not yet recruiting

TF, TFPI and Plasmin as Novel Bio-markers in Early Diagnosis of Lupus Nephritis

Conditions: Lupus Nephritis
NCT04208061

Recruiting

A Study of Darunavir in Combination With Cobicistat or Ritonavir, and Dabigatran Etexilate in Healthy Participants

Conditions: Healthy
NCT04198844

Withdrawn

The Effectiveness and Safety of Apixaban in NVAF Patients With History of Osteoporosis and/or Fracture: A Nation-wide Population Based Study

Conditions: Atrial Fibrillation